Papers
14
Total Citations
1,481
H-Index
9
About
Robert S. Svatek is a urologic oncologist whose career has been defined by a relentless pursuit of evidence-based answers to one of surgery's most consequential questions: does robotic technology meaningfully improve outcomes for bladder cancer patients undergoing radical cystectomy? As the principal architect of the landmark RAZOR trial — a multicenter, phase 3 randomized controlled study comparing robotic and open radical cystectomy — Svatek helped reshape surgical practice worldwide. That 2018 publication alone has garnered over 760 citations, establishing non-inferiority of the robotic approach and providing the field's most rigorous comparative data to date. His earlier pilot randomized trial (2012, 283 citations) laid essential groundwork, generating prospective data at a time when the literature was dominated by retrospective, bias-prone studies. Subsequent RAZOR analyses extended follow-up to three years and incorporated health-related quality of life and functional independence metrics, offering a comprehensive portrait of patient recovery. Beyond bladder cancer, Svatek has contributed systematic analyses of robotic nephrectomy with vena cava thrombectomy and explored nationwide diffusion patterns of robotic cystectomy. Collectively, his body of work has accumulated over 1,400 citations, cementing his reputation as a leading voice in surgical oncology innovation and comparative effectiveness research.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10